A reproducible and versatile system for the dynamic expansion of human pluripotent stem cells in suspension (Q48109644)

8 February 2018

title

A reproducible and versatile system for the dynamic expansion of human pluripotent stem cells in suspension (English)

1 reference

8 February 2018

1 reference

1 reference

Oliver Brüstle

1 reference

8 February 2018

Simone Haupt

object named as

Simone Haupt

1 reference

8 February 2018

author name string

Andreas Elanzew

1 reference

8 February 2018

Annika Sommer

1 reference

8 February 2018

Annette Pusch-Klein

1 reference

8 February 2018

publication date

25 June 2015

1 reference

8 February 2018

published in

Biotechnology Journal

1 reference

8 February 2018

volume

1 reference

8 February 2018

issue

1 reference

8 February 2018

page(s)

1589-1599

1 reference

8 February 2018

Human pluripotent stem cell-derived products: advances towards robust, scalable and cost-effective manufacturing strategies.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400757

Long-term microcarrier suspension cultures of human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400757

Scalable culture and cryopreservation of human embryonic stem cells on microcarriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400757

Attachment and growth of human embryonic stem cells on microcarriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400757

Xeno-free defined conditions for culture of human embryonic stem cells, neural stem cells and dopaminergic neurons derived from them

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400757

Derivation of human embryonic stem cells in defined conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400757

Self-renewal of human embryonic stem cells requires insulin-like growth factor-1 receptor and ERBB2 receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400757

Recombinant vitronectin is a functionally defined substrate that supports human embryonic stem cell self-renewal via alphavbeta5 integrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400757

Long-term self-renewal of human pluripotent stem cells on human recombinant laminin-511.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400757

Heparin promotes the growth of human embryonic stem cells in a defined serum-free medium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400757

A novel chemical-defined medium with bFGF and N2B27 supplements supports undifferentiated growth in human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400757

Chemically defined conditions for human iPSC derivation and culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400757

Passaging and colony expansion of human pluripotent stem cells by enzyme-free dissociation in chemically defined culture conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400757

Derivation, propagation and controlled differentiation of human embryonic stem cells in suspension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400757

Suspension culture of undifferentiated human embryonic and induced pluripotent stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400757

Microencapsulation technology: a powerful tool for integrating expansion and cryopreservation of human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400757

A fully defined and scalable 3D culture system for human pluripotent stem cell expansion and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400757

Scalable expansion of human induced pluripotent stem cells in the defined xeno-free E8 medium under adherent and suspension culture conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400757

Efficient and scalable expansion of human pluripotent stem cells under clinically compliant settings: a view in 2013

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400757

Microcarrier suspension cultures for high-density expansion and differentiation of human pluripotent stem cells to neural progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400757

Controlling expansion and cardiomyogenic differentiation of human pluripotent stem cells in scalable suspension culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400757

Suspension culture of human pluripotent stem cells in controlled, stirred bioreactors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400757

Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400757

The Comparison between Conditioned Media and Serum-Free Media in Human Embryonic Stem Cell Culture and Differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400757

Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400757

Harnessing the potential of induced pluripotent stem cells for regenerative medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400757

Developing high-fidelity hepatotoxicity models from pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400757

iPS cell derived neuronal cells for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400757

Aggregate culture of human embryonic stem cell-derived hepatocytes in suspension are an improved in vitro model for drug metabolism and toxicity testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400757

Cerebral organoids model human brain development and microcephaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400757

Cell aggregation optimizes the differentiation of human ESCs and iPSCs into pancreatic bud-like progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400757

Cytosystems dynamics in self-organization of tissue architecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400757

Embryonic stem cell lines derived from human blastocysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400757

Embryonic stem cell trials for macular degeneration: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400757

21 January 2018

Identifiers

DOI

10.1002/BIOT.201400757

1 reference

8 February 2018

1 reference

8 February 2018